The Seaver Autism Center for Research and Treatment at Icahn School of Medicine at Mount Sinai conducts research studies and provides care to children and adults with autism spectrum disorder.

During the past decade, Seaver Autism Center, Mount Sinai Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seaver Autism Center, Mount Sinai Medical Center" #1 collaborator was "Autism Science Foundation" with 2 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Research Foundation for Mental Hygiene, Inc." with 2 trials as a collaborator, "The Seaver Foundation" with 2 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Seaver Autism Center, Mount Sinai Medical Center" are "Autism Spectrum Disorder" (5 trials), "Autism Spectrum Disorders" (2 trials), "Autistic Disorder" (2 trials), "Behavioral Symptoms" (2 trials) and "Fragile X Syndrome" (2 trials). Many other conditions were trialed in "Seaver Autism Center, Mount Sinai Medical Center" in a lesser frequency.

Most popular intervention types in "Seaver Autism Center, Mount Sinai Medical Center" are "Drug" (7 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Aripiprazole" (2 trials), "arbaclofen" (2 trials), "Arbaclofen" (1 trials) and "Cognitive Behavioral Therapy (CBT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seaver Autism Center, Mount Sinai Medical Center" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Seaver Autism Center, Mount Sinai Medical Center". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Seaver Autism Center, Mount Sinai Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Seaver Autism Center, Mount Sinai Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".